Wnt7b is highly-expressed in many cancers and aberrant Wnt7b expression contributes to the pathogenesis of several cancers, such as pancreatic adenocarcinoma, bladder cancer and osteosarcoma (10, 14, 15) (Figure S1). Here, WNT7B is linked to urinary bladder carcinoma.